| Category | BioTech |
| Phone | 418-656-8711 |
| Employees | |
| Founded | 2002 |
| TOTAL | $9M |
| VENTURE FUNDING TOTAL | $9M |
| Series A, 5/07 Innovatech Québec Domain Associates | $9M |
Asmacure Ltée, a biotechnology company, develops therapeutics for the treatment of asthma. It involves in the development of a patented drug targeting the treatment of inflammatory diseases, particularly with reference to the lung. The company’s products include ASM-002, which is a generic agonist of nicotinic receptors. Asmacure Ltée was founded in 2002 and is based in Neuville, Canada.
